SCHEMBL14259668

SCHEMBL14259668

Cc1c(O)c(O)cc2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c12

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 3/20 0.77
PIM1 P11309 3/20 0.77
CD38 P28907 2/20 0.77
MEN1 O00255 7/20 0.67
KMT2A Q03164 7/20 0.67
KDM4E B2RXH2 6/20 0.67
CYP3A4 P08684 5/20 0.67
RECQL P46063 5/20 0.67
HSD17B10 Q99714 5/20 0.67
ALOX15 P16050 5/20 0.67
MAPT P10636 5/20 0.67
TP53 P04637 4/20 0.67
CYP2C9 P11712 4/20 0.67
LMNA P02545 3/20 0.67
APP P05067 3/20 0.67
SLCO2B1 O94956 3/20 0.67
ALDH1A1 P00352 3/20 0.67
HPGD P15428 3/20 0.67
APEX1 P27695 3/20 0.67
ALOX12 P18054 3/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29575209 0.89 AMY1A (0.77) AMY1APIM1CD38MEN1KMT2A
SCHEMBL12557418 0.89 AMY1A (0.77) AMY1APIM1CD38MEN1KMT2A
Quercetagetin SCHEMBL29690479 0.87 AMY1A (1.00) AMY1APIM1CD38MEN1KMT2A
Quercetagetin SCHEMBL29608135 0.87 AMY1A (1.00) AMY1APIM1CD38MEN1KMT2A
Quercetagetin SCHEMBL554527 0.87 AMY1A (1.00) AMY1APIM1CD38MEN1KMT2A
Quercetagetin SCHEMBL7647221 0.85 AMY1A (0.89) AMY1APIM1CD38MEN1KMT2A
Quercetagetin SCHEMBL28164757 0.84 AMY1A (0.87) AMY1APIM1CD38MEN1KMT2A
SCHEMBL9909444 0.83 MEN1 (0.75) AMY1APIM1CD38MEN1KMT2A
SCHEMBL12590257 0.83 MEN1 (0.67) AMY1APIM1CD38MEN1KMT2A
SCHEMBL31022147 0.83 AMY1A (0.81) AMY1APIM1CD38MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds GILEAD SCIENCES, INC. 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds TYMP, PNP, PIKFYVE AMY1A 4572/4885PIM1 147/4885CD38 604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.